Abstract
Purpose
Tranexamic acid is a proven drug used for reduction of intraoperative blood loss in spinal surgery. However, optimal dosing considering risk/benefits is not well established owing to the heterogeneity in patient selection and surgical procedures of previous studies. This study aimed to evaluate the effectiveness and safety of various tranexamic acid regimens in reducing perioperative blood loss in single-level posterior lumbar interbody fusion (PLIF).
Methods
Patients were randomly grouped into three different interventions: low-dose tranexamic acid (LD), high-dose tranexamic acid (HD), and placebo-controlled (PC) groups. The HD and LD groups received 10 and 5 mg/kg of bolus loading dose and 2 and 1 mg/kg of continuous infusion until 5 h after surgery, respectively. Data on patient demographics and preoperative and 24-h postoperative laboratory values were collected. Outcome parameters include intraoperative blood loss, 24-h postoperative blood loss, and blood loss during removal of the last drain.
Results
Seventy-two patients (mean age 63.3 ± 7.6 years) showed similar baseline characteristics. Intraoperatively, blood loss was reduced by the administration of tranexamic acid (P = 0.04), contributed predominantly by a difference between the LD and HD groups (123 mL; P < 0.01). The 24-h postoperative blood loss was reduced (P < 0.01), contributed predominantly by a difference between the PC and LD groups (144 mL; P = 0.02). During the removal of the last drain, statistical difference was found between the PC and HD groups (125 mL; P = 0.00). No complications or side effects from tranexamic acid use were noted.
Conclusion
Tranexamic acid administration for single-level PLIF was effective and safe in reducing perioperative blood loss in a dose-dependent manner. An HD regimen comprising 10 mg/kg of bolus loading dose and 2 mg/kg/h of continuous infusion is recommended.
Level of evidence
Level 1 study according to Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.
Similar content being viewed by others
References
Hu SS (2004) Blood loss in adult spinal surgery. Eur Spine J 13:3–5
Yuan QM, Zhao ZH, Xu BS (2017) Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. Eur Spine J 26(1):131–139. doi:10.1007/s00586-016-4899-0
Tsutsumimoto T, Shimogata M, Ohta H et al (2011) Tranexamic acid reduces perioperative blood loss in cervical laminoplasty. Spine (Phila Pa 1976) 36:1913–1918
Tse EYW (2011) Reducing perioperative blood loss and allogeneic blood transfusion inpatient undergoing major spine surgery. J Bone Jt Surg Am 93:1268–1277
Gill JB, Chin Y, Levin A et al (2008) The use of antifibrinolytic agents in spine surgery: a meta-analysis. J Bone Jt Surg Am 90:2399–2407
Sokolowski MJ, Garvey TA, Perl J II et al (2008) Prospective study of postoperative lumbar epidural hematoma: incidence and risk factors. Spine 33:108–113
Yang B, Li H, Wang D et al (2013) Systemic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery. PLoS One 8(2):e55436
Cardone D, Klein AA (2009) Perioperative blood conservation. Eur J Anaesthesiol 26:722–729
Farrokhi MR, Kazemi AP, Eftekharian HR et al (2011) Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial. J Neurosurg Anesthesiol 23:290–296
Lemaire R (2008) Strategies for blood management in orthopaedic and trauma surgery. J Bone Jt Surg Br 90(9):1128–1136
Colomina MJ, Koo M, Basora M et al (2017) Intraoperative tranexamic acid use in major spine surgery in adults: a multicentre, randomized, placebo-controlled trial. Br J Anaesth 118(3):380–390. doi:10.1093/bja/aew434
Cheriyan T, Maier SP, Bianco K et al (2015) Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J 15(4):752–761
Neilipovitz DT, Murto K, Hall L et al (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93:82–87
Wong J, El Beheiry H, Rampersaud YR et al (2008) Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 107:1479–1496
Raksakietisak M, Sathitkarnmanee B, Srisaen P et al (2015) Two doses of tranexamic acid reduce blood transfusion in complex spine surgery. Spine 40:E1257–E1263
Pilbrant A, Schannong M, Vessman J (1981) Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20(1):65–72
Sethna NF, Zurakowski D, Brustowicz RM et al (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102:727–732
Benoni G, Fredin HA (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized, double-blind study of 86 patients. J Bone Jt Surg Br 78(3):434–440
Tanaka N, Sakahashi H, Sato E et al (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Jt Surg Br 83(5):702–705
Shi H, Ou Y, Jiang D, Quan Z et al (2017) Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: a randomized trial. Medicine (Baltimore) 96(1):e5718. doi:10.1097/MD.0000000000005718
Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339:245–253
Li ZJ, Fu X, Xing D et al (2013) Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J 22:1950–1957
Elwatody S, Jamjoom Z, Elgamal E et al (2008) Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery. Spine 33(24):2577–2580
Wang Q, Liu J, Fan R et al (2013) Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. Eur Spine J 22:2035–2038
Holte K, Kehlet H (2002) Compensatory fluid administration for preoperative dehydration—does it improve outcome? Acta Anaesthesiol Scand 46(9):1089–1093
Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 4:CD000567
Porte RJ, Leebeek FW (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62:2193–2211
Neilipovitz DT (2004) Tranexamic acid for major spinal surgery, review article. Eur Spine J 139(suppl 1):S62–S65
Abou Diwan C, Sniecinski RM, Szlam F et al (2011) Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients. J Chromatogr B Analyt Technol Biomed Life Sci 879(78):533–536
Yamasaki S, Masuhara K, Fuji T (2001) Tranexamic acid reduces postoperative blood loss in cement less total hip arthroplasty. J Bone Jt Surg Am 87(4):766–770
Huang Cheng YML (2011) Tranexamic acid for the elderly with multi segmental spinal stenosis perioperative blood loss and the safety assessment of the impact. Chin J Postgrad Med 10:17–22
Ker K, Prieto-Merino D, Roberts I (2013) Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 100:1271–1279
Zufferey P, Merquiol F, Laporte S et al (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopaedic surgery? Anesthesiology 105:1034–1046
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Cheung Kue-Kim, Ki-Tack Kim, Yong-chan Kim, Hyung-Suk Juh, Hyo-jong Kim, Hyeon-Soo Kim, Se jung Hong, and Hwee Weng Dennis Hey declare that they have no conflict of interest.
Ethics approval
Ethics approval was obtained from the institutional review board before the commencement of this study. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.
Funding
No funds were received in support of this work.
Rights and permissions
About this article
Cite this article
Kim, KT., Kim, CK., Kim, YC. et al. The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. Eur Spine J 26, 2851–2857 (2017). https://doi.org/10.1007/s00586-017-5230-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-017-5230-4